Half-year report · HY
4565.TEDINET S100YVBU
Period2026-01-01 → 2026-06-30
Filed2026-08-07
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥18.9bn | 2026-01-01 → 2026-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥29.6bn | 2025-01-01 → 2025-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥15.1bn | 2025-01-01 → 2025-06-30 | Cons. | Revenue IFRS |
| Operating income | ¥1.9bn | 2026-01-01 → 2026-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | −¥2.8bn | 2025-01-01 → 2025-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥1.4bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥14.9bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | −¥3.7bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥1.6bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥12.5bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | −¥3.1bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥1.6bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss IFRS |
| Net income | −¥3.1bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥132.4bn | at 2026-06-30 | Cons. | Assets IFRS |
| Total assets | ¥134.8bn | at 2025-12-31 | Cons. | Assets IFRS |
| Total assets | ¥144.7bn | at 2025-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥67.6bn | at 2026-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥73.8bn | at 2025-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥64.8bn | at 2026-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥61.0bn | at 2025-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥65.9bn | at 2025-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥68.5bn | at 2024-12-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥64.8bn | at 2026-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥61.0bn | at 2025-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥65.9bn | at 2025-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥17.7bn | at 2026-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥20.4bn | at 2025-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥33.0bn | at 2025-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥32.3bn | at 2024-12-31v | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥4.0bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | −¥2.7bn | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥433m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥4.3bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥5.4bn | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | ¥3.5bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥2.6bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥16.0bn | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥3.4bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥17.54 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-138.8 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥-34.82 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥15.86 | 2026-01-01 → 2026-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-138.8 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥-34.82 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 49.0% | at 2026-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 45.3% | at 2025-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 45.5% | at 2025-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 546
| Item | Context | Value | Unit |
|---|---|---|---|
| Income taxes paid ope cf IFRS | InterimDuration | -209000000 | JPY |
| Income taxes paid ope cf IFRS | Prior1InterimDuration | -158000000 | JPY |
| Income taxes refund ope cf IFRS | InterimDuration | 2000000 | JPY |
| Income taxes refund ope cf IFRS | Prior1InterimDuration | 1218000000 | JPY |
| Net cash provided by used in operating activities IFRS | InterimDuration | 3975000000 | JPY |
| Net cash provided by used in operating activities IFRS | Prior1InterimDuration | 433000000 | JPY |
| Purchase of property plant and equipment inv cf IFRS | InterimDuration | -356000000 | JPY |
| Purchase of property plant and equipment inv cf IFRS | Prior1InterimDuration | -199000000 | JPY |
| Purchase of intangible assets inv cf IFRS | InterimDuration | -5064000000 | JPY |
| Purchase of intangible assets inv cf IFRS | Prior1InterimDuration | -153000000 | JPY |
| Proceeds from sale of investment securities inv cf IFRS | InterimDuration | 3290000000 | JPY |
| Proceeds from sale of investment securities inv cf IFRS | Prior1InterimDuration | － | JPY |
| Purchase of investment securities inv cf IFRS | InterimDuration | -2139000000 | JPY |
| Purchase of investment securities inv cf IFRS | Prior1InterimDuration | － | JPY |
| Net decrease increase in time deposits inv cf IFRS | InterimDuration | － | JPY |
| Net decrease increase in time deposits inv cf IFRS | Prior1InterimDuration | 3850000000 | JPY |
| Other inv cf IFRS | InterimDuration | -79000000 | JPY |
| Other inv cf IFRS | Prior1InterimDuration | 17000000 | JPY |
| Net cash provided by used in investing activities IFRS | InterimDuration | -4347000000 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1InterimDuration | 3515000000 | JPY |
| Net increase decrease in short term borrowings fin cf IFRS | InterimDuration | 777000000 | JPY |
| Net increase decrease in short term borrowings fin cf IFRS | Prior1InterimDuration | － | JPY |
| Repayments of long term borrowings fin cf IFRS | InterimDuration | -2900000000 | JPY |
| Repayments of long term borrowings fin cf IFRS | Prior1InterimDuration | -2900000000 | JPY |
| Repayments of lease obligations fin cf IFRS | InterimDuration | -446000000 | JPY |
| Repayments of lease obligations fin cf IFRS | Prior1InterimDuration | -450000000 | JPY |
| Other fin cf IFRS | InterimDuration | -7000000 | JPY |
| Other fin cf IFRS | Prior1InterimDuration | -0 | JPY |
| Net cash provided by used in financing activities IFRS | InterimDuration | -2576000000 | JPY |
| Net cash provided by used in financing activities IFRS | Prior1InterimDuration | -3350000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | InterimDuration | 331000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1InterimDuration | 131000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | InterimDuration | -2616000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | Prior1InterimDuration | 729000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 20365000000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 32268000000 | JPY |
| Cash and cash equivalents IFRS | InterimInstant | 17748000000 | JPY |
| Cash and cash equivalents IFRS | Prior1InterimInstant | 32997000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2026-08-07 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第37期中(自 2026年１月１日 至 2026年６月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ネクセラファーマ株式会社 | |
| Company name in english cover page | FilingDateInstant | Nxera Pharma Co., Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表執行役社長CEO クリストファー・カーギル | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区赤坂九丁目７番２号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03(5962)5718 (代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)チーフ・アカウンティング・オフィサー キーラン・ジョンソン | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区赤坂九丁目７番２号 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |